Optimizing HIV preventive therapy administration is key to improved uptake in vulnerable populations. Here, the authors report that subcutaneous administration of broadly neutralizing antibodies formulated with EDP is safe while reducing infusion duration and number of injections in healthy female participants.
- Sharana Mahomed
- Farzana Osman
- Salim S. Abdool Karim
